NOVEL Pathogen Detection Platform technology

CTS PATHOGEN DETECTION TEST TO DETECT THE STATUS OF VARIOUS CURRENT INFECTIONS

Simpler, more effective, more accessible and more cost-efficient DIAGNOSTICS

Our pathogen detection platform technology has been developed at Harvard University to provide a novel POC diagnostic test using microfluidic based-technology to deliver performance referenced to lab-based assays while being fast, simple and cost-effective. With fast and accurate results in 30 minutes, our pathogen detection test will give infected patients the information they need to get care quickly and limit the amount of time they unknowingly spread the infection to others.

 

With fast and accurate results in a few minutes, our Pathogen detection test will give infected patients the information they need to get care quickly and limit the amount of time they unknowingly spread the virus to others. We are also developing our new technology to use saliva as a promising sample for facilitating testing due to the ease, safety, and non-invasive nature of its collection.  

 

CTS mobile application: 

Our smart, cloud-based technology, ensures the secure real-time transfer of results from the CTS instrument to a patient’s record.
 

With our data integration, which is block-chain protected, people can receive and monitor their test results via smartphone. The smart connectivity allows people who test negative to get a temporary digital health pass and people who test positive to prevent spreading the infection and follow-up their treatment at the right time and right settings.

Test BENEFITS:

The use of a CT-Scientific Point-of-Care test will enable the physician to verify infection quickly, begin proper treatment and then prevent further spread of infection.

. Highly accurate
. Simple & user-friendly
. Smart & connected
. All common clinical samples
. Portable & versatile
. Fast detection